Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,047,304
  • Shares Outstanding, K 28,168
  • Annual Sales, $ 2,109 M
  • Annual Income, $ 404,390 K
  • EBIT $ 536 M
  • EBITDA $ 565 M
  • 60-Month Beta 1.43
  • Price/Sales 7.63
  • Price/Cash Flow 40.97
  • Price/Book 54.83

Options Overview Details

View History
  • Implied Volatility 36.86% (+0.81%)
  • Historical Volatility 26.28%
  • IV Percentile 38%
  • IV Rank 22.96%
  • IV High 70.52% on 04/11/25
  • IV Low 26.83% on 08/15/25
  • Expected Move (DTE 22) 29.83 (5.22%)
  • Put/Call Vol Ratio 21.00
  • Today's Volume 22
  • Volume Avg (30-Day) 71
  • Put/Call OI Ratio 1.79
  • Today's Open Interest 1,309
  • Open Int (30-Day) 3,208
  • Expected Range 542.03 to 601.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 4.18
  • Number of Estimates 4
  • High Estimate 4.35
  • Low Estimate 4.09
  • Prior Year 3.67
  • Growth Rate Est. (year over year) +13.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
530.96 +7.70%
on 12/04/25
626.26 -8.69%
on 11/25/25
-46.63 (-7.54%)
since 11/24/25
3-Month
484.00 +18.15%
on 09/25/25
626.26 -8.69%
on 11/25/25
+74.54 (+14.99%)
since 09/24/25
52-Week
250.05 +128.70%
on 04/22/25
626.26 -8.69%
on 11/25/25
+229.17 (+66.87%)
since 12/24/24

Most Recent Stories

More News
2 Profitable Stocks to Keep an Eye On and 1 We Find Risky

2 Profitable Stocks to Keep an Eye On and 1 We Find Risky

MEDP : 571.86 (+0.38%)
HNI : 42.33 (+0.28%)
NVR : 7,385.29 (+0.64%)
1 Volatile Stock to Target This Week and 2 We Turn Down

1 Volatile Stock to Target This Week and 2 We Turn Down

MEDP : 571.86 (+0.38%)
RGEN : 165.66 (-0.42%)
AMTM : 29.91 (+1.53%)
Medpace (NASDAQ:MEDP): Strongest Q3 Results from the Drug Development Inputs & Services Group

Medpace (NASDAQ:MEDP): Strongest Q3 Results from the Drug Development Inputs & Services Group

MEDP : 571.86 (+0.38%)
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know

FTRE : 17.70 (-1.17%)
MEDP : 571.86 (+0.38%)
TXG : 16.69 (+1.15%)
BTSG : 37.73 (-0.13%)
QDEL : 28.91 (+1.12%)
1 Cash-Producing Stock Worth Your Attention and 2 We Ignore

1 Cash-Producing Stock Worth Your Attention and 2 We Ignore

MEDP : 571.86 (+0.38%)
EXPI : 9.52 (-0.42%)
MANH : 175.29 (+0.78%)
2 Mooning Stocks to Research Further and 1 We Question

2 Mooning Stocks to Research Further and 1 We Question

MEDP : 571.86 (+0.38%)
ENS : 149.77 (-0.03%)
WMS : 149.36 (+0.30%)
1 Mid-Cap Stock to Target This Week and 2 We Ignore

1 Mid-Cap Stock to Target This Week and 2 We Ignore

MEDP : 571.86 (+0.38%)
DG : 135.45 (+0.89%)
SGI : 90.05 (+0.29%)
3 Cash-Heavy Stocks Worth Your Attention

3 Cash-Heavy Stocks Worth Your Attention

MEDP : 571.86 (+0.38%)
CPNG : 22.80 (+1.65%)
LOPE : 168.21 (+0.02%)
5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call

5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call

MEDP : 571.86 (+0.38%)
MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook

MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook

MEDP : 571.86 (+0.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 583.01
2nd Resistance Point 577.94
1st Resistance Point 574.90
Last Price 571.86
1st Support Level 566.79
2nd Support Level 561.72
3rd Support Level 558.68

See More

52-Week High 626.26
Last Price 571.86
Fibonacci 61.8% 482.54
Fibonacci 50% 438.15
Fibonacci 38.2% 393.76
52-Week Low 250.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar